How many OPV rounds are required to stop wild polio virus circulation in a developed country? Lessons from the Israeli experience

Diana Tasher; Galia Rahav; Hagai Levine; Danit Sofer; Nehama Linder; Emilia Anis; Tamy Shohat; Yosi Manor; Eran Kopel; Lester M Shulman; Ella Mendelson; Itamar Shalit; Eli Somekh

doi:10.1016/j.vaccine.2015.11.066

How many OPV rounds are required to stop wild polio virus circulation in a developed country? Lessons from the Israeli experience

Vaccine. 2016 Jan 12;34(3):299-301. doi: 10.1016/j.vaccine.2015.11.066. Epub 2015 Dec 9.

Authors

Diana Tasher¹, Galia Rahav², Hagai Levine³, Danit Sofer⁴, Nehama Linder⁵, Emilia Anis⁶, Tamy Shohat⁷, Yosi Manor⁴, Eran Kopel⁸, Lester M Shulman⁴, Ella Mendelson⁴, Itamar Shalit⁹, Eli Somekh¹⁰

Affiliations

¹ The Paediatric Infectious Diseases Unit, Wolfson Medical Centre, Holon, Israel; The Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel; Israeli National Polio Accreditation Committee, Wolfson Medical Center, Holon, Israel.
² The Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel; Infectious Disease Unit, Sheba Medical Centre, Tel Hashomer, Israel; Israeli National Polio Accreditation Committee, Wolfson Medical Center, Holon, Israel.
³ Braun School of Public Health and Community Medicine, Hebrew University-Hadassah, Jerusalem, Israel; Israeli National Polio Accreditation Committee, Wolfson Medical Center, Holon, Israel.
⁴ The Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel; Central Virology Laboratory, Public Health Services, Ministry of Health, The Chaim Sheba Medical Centre, Tel Hashomer, Israel; Israeli National Polio Accreditation Committee, Wolfson Medical Center, Holon, Israel.
⁵ The Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel; Department of Neonatology, Rabin Medical Center, Petach Tikva, Israel; Israeli National Polio Accreditation Committee, Wolfson Medical Center, Holon, Israel.
⁶ Braun School of Public Health and Community Medicine, Hebrew University-Hadassah, Jerusalem, Israel; The Division of Epidemiology, Public Health Services, Ministry of Health, Jerusalem, Israel; Public Health Services, Ministry of Health, Jerusalem, Israel; Israeli National Polio Accreditation Committee, Wolfson Medical Center, Holon, Israel.
⁷ The Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel; Israel Center for Diseases Control, Israel Ministry of Health, Tel Hashomer, Israel; Israeli National Polio Accreditation Committee, Wolfson Medical Center, Holon, Israel.
⁸ The Division of Epidemiology, Public Health Services, Ministry of Health, Jerusalem, Israel; Public Health Services, Ministry of Health, Jerusalem, Israel; Israeli National Polio Accreditation Committee, Wolfson Medical Center, Holon, Israel.
⁹ The Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel; Israeli National Polio Accreditation Committee, Wolfson Medical Center, Holon, Israel.
¹⁰ The Paediatric Infectious Diseases Unit, Wolfson Medical Centre, Holon, Israel; The Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel; Israeli National Polio Accreditation Committee, Wolfson Medical Center, Holon, Israel. Electronic address: [email protected].

PMID: 26679402
DOI: 10.1016/j.vaccine.2015.11.066

No abstract available

Keywords: Circulation; IPV; OPV; Outbreak; Poliovirus.

MeSH terms

Adult
Child
Child, Preschool
Developed Countries
Disease Eradication*
Disease Transmission, Infectious / prevention & control
Female
Humans
Infant
Israel / epidemiology
Male
Poliomyelitis / epidemiology*
Poliomyelitis / prevention & control*
Poliovirus / isolation & purification*
Poliovirus Vaccine, Oral / administration & dosage*
Poliovirus Vaccine, Oral / immunology*
Sewage / virology*
Young Adult

Substances

Poliovirus Vaccine, Oral
Sewage